Steve Hahn, CEO of Harbinger Health explains Harbinger’s big leap to identify cancer early through a simple blood test and how the company is focusing on access, performance, and ensuring doctors and patients will have the information they need as Harbinger prepares to advance its pioneering product to market. More from Flagship @ JPM2025 here.
Related Companies
- Harbinger Health Founded: 2018
